Czy lek antyarytmiczny może poprawiać odległe rokowanie u chorych z migotaniem przedsionków? Komentarz
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
cze 30, 2009
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Trusz-Gluza, M. (2009). Czy lek antyarytmiczny może poprawiać odległe rokowanie u chorych z migotaniem przedsionków?. Medycyna Faktów , 2(2(3), 13-15. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2659
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Kerr C.R., Humphries K.H., Talajic M., Klein G.J., Connolly S.J., Green M., Boone J., Sheldon R., Dorian P., Newman D.: Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am. Heart. J. 2005; 149: 489-496.
2. Nieuwlaat R., Prins M.H., Le Heuzey J.Y., Vardas P.E., Aliot E., Santini M., Cobbe S.M., Widdershoven J.W., Baur L.H., Lévy S., Crijns H.J.: Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 2008; 29: 1181-1189.
3. The AFFIRM Investigators. A comparison of rate control and rhythm control In patients with atrial fibrillation. N. Engl. J. Med. 2002; 347: 1825-1833.
4. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the AFFIRM study. Circulation 2004; 109: 1509-1513.
5. Hohnloser S.H., Crinjs H.J.G.M., van Eickels M. et al.: Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 2009; 360: 668-678.
6. Singh B.N., Connolly S.J., Crinjs H.J. et al.: Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 2007; 357: 987-999.
7. Kober L., Torp-Pedersen C., McMurray J.J.V. et al.: Increased mortality after dronedarone therapy for severe heart failure. N. Engl. J. Med. 2008; 358: 2678-2687.
8. Hohnloser S.H., Connolly S.J., Crinjs H.J.G.M.: Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J. Cardiovasc. Electrophysiol. 2008; 19: 69-73
9. Nabauer M., Gerth A., Limbourg T. et al. The registry of the german competence network on atrial fibrillation: patients characteristics and initial management. Europace 2009; 11: 423-434.
2. Nieuwlaat R., Prins M.H., Le Heuzey J.Y., Vardas P.E., Aliot E., Santini M., Cobbe S.M., Widdershoven J.W., Baur L.H., Lévy S., Crijns H.J.: Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur. Heart J. 2008; 29: 1181-1189.
3. The AFFIRM Investigators. A comparison of rate control and rhythm control In patients with atrial fibrillation. N. Engl. J. Med. 2002; 347: 1825-1833.
4. The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the AFFIRM study. Circulation 2004; 109: 1509-1513.
5. Hohnloser S.H., Crinjs H.J.G.M., van Eickels M. et al.: Effect of dronedarone on cardiovascular events in atrial fibrillation. N. Engl. J. Med. 2009; 360: 668-678.
6. Singh B.N., Connolly S.J., Crinjs H.J. et al.: Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 2007; 357: 987-999.
7. Kober L., Torp-Pedersen C., McMurray J.J.V. et al.: Increased mortality after dronedarone therapy for severe heart failure. N. Engl. J. Med. 2008; 358: 2678-2687.
8. Hohnloser S.H., Connolly S.J., Crinjs H.J.G.M.: Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. J. Cardiovasc. Electrophysiol. 2008; 19: 69-73
9. Nabauer M., Gerth A., Limbourg T. et al. The registry of the german competence network on atrial fibrillation: patients characteristics and initial management. Europace 2009; 11: 423-434.